Outcomes of patients in South Yorkshire with PDL-1 positive or negative locally advanced or metastatic squamous (NSCLC) treated with first line pembrolizumab in combination with carboplatin and paclitaxel

Lung Cancer(2023)

引用 0|浏览2
暂无评分
关键词
first line pembrolizumab,paclitaxel,carboplatin
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要